BORIS BLECHACZ to Middle Aged
This is a "connection" page, showing publications BORIS BLECHACZ has written about Middle Aged.
Connection Strength
0.034
-
Clinical Characteristics and Adverse Impact of Hepatotoxicity due to Immune Checkpoint Inhibitors. Am J Gastroenterol. 2020 02; 115(2):251-261.
Score: 0.007
-
Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study. Am J Gastroenterol. 2019 02; 114(2):250-257.
Score: 0.006
-
Endoscopic and Histologic Features of Immune Checkpoint Inhibitor-Related Colitis. Inflamm Bowel Dis. 2018 07 12; 24(8):1695-1705.
Score: 0.006
-
Adult cancer-related hemophagocytic lymphohistiocytosis - a challenging diagnosis: a case report. J Med Case Rep. 2017 Jun 27; 11(1):172.
Score: 0.006
-
Effect of hepatitis C virus infection in patients with cancer: addressing a neglected population. J Natl Compr Canc Netw. 2015 Jan; 13(1):41-50.
Score: 0.005
-
Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors. Gastroenterology. 2012 Apr; 142(4):1021-1031.e15.
Score: 0.004